Mel Blumenthal

652 total citations
7 papers, 444 citations indexed

About

Mel Blumenthal is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Pharmacology. According to data from OpenAlex, Mel Blumenthal has authored 7 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 2 papers in Economics and Econometrics and 1 paper in Pharmacology. Recurrent topics in Mel Blumenthal's work include Heart Failure Treatment and Management (4 papers), Cardiac pacing and defibrillation studies (2 papers) and Ethics in Clinical Research (1 paper). Mel Blumenthal is often cited by papers focused on Heart Failure Treatment and Management (4 papers), Cardiac pacing and defibrillation studies (2 papers) and Ethics in Clinical Research (1 paper). Mel Blumenthal collaborates with scholars based in United States, Germany and Poland. Mel Blumenthal's co-authors include Salim Yusuf, Shamir R. Mehta, Bernard J. Gersh, Keith A.A. Fox, Feng Zhao, Patrick Commerford, Andrzej Budaj, Thomas Wittlinger, Kate Gelperin and John Ilgenfritz and has published in prestigious journals such as Circulation, CHEST Journal and European Heart Journal.

In The Last Decade

Mel Blumenthal

7 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mel Blumenthal United States	5	304	107	81	70	48	7	444
Frits R. Rosendaal Netherlands	3	100 0.3×	43 0.4×	42 0.5×	61 0.9×	30 0.6×	4	373
John G. Ferguson United States	12	190 0.6×	80 0.7×	14 0.2×	104 1.5×	13 0.3×	20	490
M. Sudlow United Kingdom	10	592 1.9×	50 0.5×	103 1.3×	244 3.5×	166 3.5×	14	826
J. Rex Dawson United Kingdom	4	211 0.7×	100 0.9×	29 0.4×	51 0.7×	5 0.1×	5	346
T. Ivert Sweden	4	485 1.6×	169 1.6×	23 0.3×	58 0.8×	17 0.4×	4	602
Katherine Berezny United States	8	156 0.5×	63 0.6×	33 0.4×	28 0.4×	29 0.6×	9	432
Wesley G. Byerly United States	10	86 0.3×	53 0.5×	60 0.7×	39 0.6×	11 0.2×	16	318
Dogan Fidan United Kingdom	10	231 0.8×	106 1.0×	50 0.6×	100 1.4×	221 4.6×	14	530
Thomas Harkins United States	7	122 0.4×	38 0.4×	18 0.2×	54 0.8×	107 2.2×	12	325
Eliana Vieira Santucci Brazil	8	161 0.5×	151 1.4×	56 0.7×	69 1.0×	3 0.1×	16	390

Countries citing papers authored by Mel Blumenthal

Since Specialization

Citations

This map shows the geographic impact of Mel Blumenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mel Blumenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mel Blumenthal more than expected).

Fields of papers citing papers by Mel Blumenthal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mel Blumenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mel Blumenthal. The network helps show where Mel Blumenthal may publish in the future.

Co-authorship network of co-authors of Mel Blumenthal

This figure shows the co-authorship network connecting the top 25 collaborators of Mel Blumenthal. A scholar is included among the top collaborators of Mel Blumenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mel Blumenthal. Mel Blumenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Duley, Lelia, Karen H. Antman, Joseph P. Arena, et al.. (2008). Specific barriers to the conduct of randomized trials. Clinical Trials. 5(1). 40–48. 129 indexed citations

2.

Yusuf, Salim, Shamir R. Mehta, Feng Zhao, et al.. (2003). Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes. Circulation. 107(7). 966–972. 193 indexed citations

3.

Sharma, Satish, et al.. (1999). The Hemodynamic Effects of Long-Term ACE Inhibition with Fosinopril in Patients with Heart Failure. American Journal of Therapeutics. 6(4). 181–190. 4 indexed citations

4.

Sica, Domenic A., et al.. (1998). Fosinopril: Emerging Considerations and Implications for Angiotensin‐Converting Enzyme Inhibitor Therapy. Cardiovascular Drug Reviews. 16(4). 319–345. 4 indexed citations

5.

Brown, Edward J., et al.. (1995). Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. The American Journal of Cardiology. 75(8). 596–600. 32 indexed citations

6.

Erhardt, Leif, et al.. (1995). Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. European Heart Journal. 16(12). 1892–1899. 63 indexed citations

7.

Blumenthal, Mel, et al.. (1988). Cardiac Arrest during Dipyridamole Imaging. CHEST Journal. 93(5). 1103–1104. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact